Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
Stocks
600196
CNE000000X38
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 23.58 CNY | -0.34% |
|
+5.69% | -10.99% |
| 11-05 | Fosun Pharma Subsidiary Waives Right to Receive Transferred Shares in Biologics-Focused Equity Fund | MT |
| 11-04 | Fosun Pharma Unit Begins Trial of FXS6837 Capsules for Gemoglobinuria in China | MT |
| Market Cap | 57.85B 8.67B 7.73B 7.07B 6.44B 12.13B 819B 12.46B 84.9B 33.95B 434B 32.55B 31.85B 1,369B | P/E 2026 * |
17.3x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 70.66B 10.59B 9.44B 8.63B 7.86B 14.82B 1,001B 15.22B 104B 41.47B 530B 39.75B 38.9B 1,673B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 1.79x |
| Free-Float |
62.56% | Yield 2026 * |
1.81% | Yield 2027 * | 2.07% |
| 1 day | -0.34% | ||
| 1 week | +5.69% | ||
| Current month | +4.06% | ||
| 1 month | -1.83% | ||
| 3 months | +2.75% | ||
| 6 months | -5.26% | ||
| Current year | -10.99% |
| 1 week | 22.51 |  | 23.79 |
| 1 month | 22.1 | | 24.24 |
| Current year | 20.85 | | 28.71 |
| 1 year | 20.85 | | 29.13 |
| 3 years | 20.38 | | 33.1 |
| 5 years | 20.38 | | 58.95 |
| 10 years | 20.38 | | 91.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 24/06/2025 |
Zhi Huang
DFI | Director of Finance/CFO | - | 02/04/2026 |
Jing Li
PSD | President | 53 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 01/04/1994 |
Yi Liu
BRD | Director/Board Member | 50 | 02/12/2025 |
Dong Hui Pan
BRD | Director/Board Member | 56 | 30/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/05/25 | Sell | Chief Executive Officer | 87,448 | 0.0041% | ||
| 30/05/25 | Sell | Executive/Senior Manager | 31,790 | 0.0015% | ||
| 30/05/25 | Sell | Chairman | 63,614 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | +5.69% | -16.23% | -16.94% | 8.7B | |
| +0.42% | -3.95% | +45.25% | +128.77% | 1,216B | |
| +0.22% | -0.12% | +45.94% | +79.87% | 656B | |
| +0.52% | -1.89% | +32.09% | +104.90% | 509B | |
| -0.89% | -3.74% | +46.42% | +63.74% | 384B | |
| +0.01% | -2.09% | +70.67% | +40.31% | 362B | |
| -0.98% | -0.70% | +30.34% | +57.69% | 311B | |
| -0.83% | -0.42% | +8.32% | +35.29% | 293B | |
| +0.28% | -1.06% | +46.09% | +68.99% | 249B | |
| -0.08% | -1.77% | +35.86% | +106.63% | 208B | |
| Average | -0.18% | +0.89% | +34.47% | +66.92% | 419.65B | |
| Weighted average by Cap. | -0.02% | +0.04% | +41.83% | +87.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.71B 6.25B 5.57B 5.1B 4.64B 8.75B 591B 8.98B 61.21B 24.48B 313B 23.46B 22.96B 987B | 43.42B 6.51B 5.8B 5.3B 4.83B 9.11B 615B 9.35B 63.73B 25.48B 326B 24.43B 23.91B 1,028B |
| Net income | 3.53B 529M 472M 431M 393M 740M 50.01B 760M 5.18B 2.07B 26.48B 1.99B 1.94B 83.57B | 4.2B 630M 561M 513M 468M 881M 59.52B 905M 6.17B 2.47B 31.52B 2.36B 2.31B 99.47B |
| Net Debt | 12.81B 1.92B 1.71B 1.57B 1.43B 2.69B 181B 2.76B 18.8B 7.52B 96.1B 7.21B 7.05B 303B | 19.74B 2.96B 2.64B 2.41B 2.2B 4.14B 280B 4.25B 28.98B 11.59B 148B 11.11B 10.87B 467B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | CN¥23.58 | -0.34% | 17,812,240 |
| 05/11/26 | CN¥23.66 | +1.68% | 24,348,536 |
| 04/11/26 | CN¥23.27 | +1.13% | 21,929,144 |
| 03/11/26 | CN¥23.01 | +1.01% | 22,389,032 |
| 02/11/26 | CN¥22.78 | +0.53% | 15,143,022 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
Select your edition
All financial news and data tailored to specific country editions
